Access cutting-edge covid-19 treatment through this clinical trial at a research site in Meridian. Study-provided care at no cost to qualified participants.
Access covid-19 specialists in Meridian at no cost
This study follows strict safety protocols and ethical guidelines
All study-related covid-19 treatment provided free
The purpose of this study is to evaluate the immunogenicity, reactogenicity, and safety, of mRNA-1083 multicomponent influenza and COVID-19 vaccine in adults ≥18 to \<65 years of age.
Sponsor: ModernaTX, Inc.
Check if you qualify for this covid-19 clinical trial in Meridian, ID
If you're searching for covid-19 treatment options in Meridian, ID, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Meridian research site is actively enrolling participants for this clinical trial. You'll receive care from experienced covid-19 specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.